HLA and juvenile chronic polyarthritis

Area of Science:

• Immunogenetics
• Rheumatology
• Pediatrics

Background:

• Juvenile chronic polyarthritis (J.C.P.) is a significant rheumatologic condition in children.
• The role of human leukocyte antigen (HLA) B27 in J.C.P. and its subtypes requires further elucidation.

Purpose of the Study:

• To investigate the association between HLA antigen B27 and different clinical subtypes of J.C.P.
• To determine the long-term outcomes and risk factors for J.C.P. progression.

Main Methods:

• Retrospective analysis of 35 J.C.P. patients with long-term follow-up.
• Clinical evaluation, serology, and X-ray assessments were performed.
• Patients were classified into four groups based on disease progression and characteristics.

Main Results:

• A significantly higher incidence of HLA antigen B27 was observed in J.C.P. patients (57%) compared to the general population (n=1,000).
• Patients progressing to ankylosing spondylitis (Group 1) or developing sacroiliitis (Group 2) showed a high prevalence of HLA B27 (19/20).
• Only one patient in the J.C.P. without sacroiliitis (Group 3) and juvenile rheumatoid arthritis (Group 4) groups tested positive for HLA B27.

Conclusions:

• HLA antigen B27 positivity in J.C.P. patients is strongly associated with the development of sacroiliitis and acute uveitis.
• The study supports classifying J.C.P. subtypes, including juvenile ankylosing spondylitis and juvenile rheumatoid arthritis, based on clinical and serological findings.
• The findings suggest that HLA B27 status is a critical predictive marker for disease course in J.C.P.